More than 9000 tonnes of moulded Type I pharmaceutical glass containers and 4000 tonnes of tubular vials and ampoules (corresponding to more than 700 million pieces) are produced annually at the Vemula (India) glassworks of SGD Pharma. Sardar Akshay Singh, Managing Director of SGD Pharma India, spoke to Glass Worldwide (preferred international AIGMF journal) about the fully integrated facility’s extensive capabilities, prospects and opportunities.
Forster Karl-Heinz
Could you sum up your career for us?
I started my apprenticeship as a utilities electrician at “Saint-Gobain Desjonquere” in Kipfenberg in 1984. After three and a half years of vocational training, I graduated and kept working there at our electrical workshop. In 1991/92 I successfully completed my Master electrician training in the city of Nuremberg, before returning to the electrical workshop of SGD Pharma in Kipfenberg. In 1996, I was appointed Project Leader for inspection machines, before taking up the position of Cold End Manager in 2003.
As the first commercial ready-to-use (RTU) molded glass vial system that reduces costs while simultaneously improving quality, the new Sterinity platform is an efficient solution to the challenges associated with aseptic filling.